All In Biotech

Drug Trial Radar · NCT07793513

Study of BK1803 in Healthy Infants

Confirmatory Study of BK1803 in Healthy Infants (Comparative Study Using GOBIK Aqueous Suspension Syringes and Bimmugen® Injection as a Control)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 344 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

344

Planned (sponsor's estimate)

Start

Oct 21, 2026

Primary completion

Apr 2029

Study completion Apr 2029

Sponsor

Lead sponsor
Tanabe Pharma CorporationIndustry
Sponsor type
Industry
Collaborators
The Research Foundation for Microbial Diseases of Osaka University (BIKEN)
First posted
Aug 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 2 months, up to 6 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a phase 3, randomized, observer-blinded, active-controlled, multicenter study to evaluate the immunogenicity and safety of BK1803 in healthy infants aged 2 months to less than 7 months. Participants will be randomized to receive either BK1803 or a control regimen consisting of GOBIK Aqueous Suspension Syringes and Bimmugen® Injection. The primary objective is to demonstrate the noninferiority of BK1803 compared with the control in terms of antibody seroprotection rates against hepatitis B surface (HBs) antigen, Haemophilus influenzae type b (Hib), pertussis, diphtheria, tetanus, and poliovirus. Safety will also be assessed throughout the study.

Conditions

  • Pertussis
  • Diphtheria
  • Tetanus
  • Poliomyelitis
  • Hepatitis B
  • Haemophilus Influenzae Type b

Interventions

  • BK1803Biological

    BK1803 is a combination vaccine administered intramuscularly according to the study vaccination schedule, including primary and booster immunizations.

  • GOBIK Aqueous Suspension SyringesBiological

    GOBIK Aqueous Suspension Syringes is a combination vaccine administered intramuscularly according to the study vaccination schedule.

  • Bimmugen® InjectionBiological

    Bimmugen® Injection is a hepatitis B vaccine administered subcutaneously according to the study vaccination schedule.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Antibody seroprotection rates against vaccine antigens in the BK1803 of Main CohortTime frame: 4 weeks from the post-primary immunization of BK1803 in Main Cohort (Visit4)
  2. Antibody seroprotection rates against vaccine antigens for HBs antigen in the Control of Main CohortTime frame: 4 weeks from the post-booster immunization of Bimmugen in Main Cohort (Visit6)
  3. The antibody seroprotection rates against vaccine antigens for PRP, PT and FHA, diphtheria toxin, tetanus toxin, and attenuated poliovirus in the Control of Main CohortTime frame: 4 weeks from the post-primary immunization of GOBIK in Main Cohort (Visit4)

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • Fukui Aiiku Hospital

    Fukui-shi, Fukui, Japan · Recruiting

  • Oda Children's Allergy Clinic

    Fukuoka, Fukuoka, Japan · Recruiting

  • Morooka Chirdren's Chikushi-dori Clinic

    Fukuoka, Fukuoka, Japan · Recruiting

  • Shindo children's clinic

    Fukuoka, Fukuoka, Japan · Recruiting

  • Kurokawa Michiko Pediatric Clinic

    Fukuoka, Fukuoka, Japan · Recruiting

  • Japanese Red Cross Fukuoka Hospital

    Fukuoka, Fukuoka, Japan · Recruiting

  • Isesaki Municipal Hospital

    Isesaki, Gunma, Japan · Recruiting

  • Japanese Red Cross Maebashi Hospital

    Maebashi, Gunma, Japan · Recruiting

  • Yoshimitsu Pediatric Clinic

    Hiroshima, Hiroshima, Japan · Recruiting

  • Taniguchi Children Clinic

    Hiroshima, Hiroshima, Japan · Recruiting

  • Ishikari Kids Clinic

    Ishikari-shi, Hokkaido, Japan · Recruiting

  • Hibarigaoka Kodomo Clinic

    Sapporo, Hokkaido, Japan · Recruiting

  • Araki Children Clinic

    Sapporo, Hokkaido, Japan · Recruiting

  • Japan Community Healthcare Organization Hokkaido Hospital

    Sapporo, Hokkaido, Japan · Recruiting

  • Kumagai Children's Clinic

    Amagasaki, Hyōgo, Japan · Recruiting

  • Hamami Kodomo Clinic

    Chigasaki, Kanagawa, Japan · Recruiting

  • Kawasaki Municipal Hospital

    Kawasaki-shi, Kanagawa, Japan · Recruiting

  • Sagamihara Kyodo Hospital

    Sagamihara, Kanagawa, Japan · Recruiting

  • Kochi Health Sciences Center

    Kochi, Kochi, Japan · Recruiting

  • Sakuranbo Kodomo Clinic

    Kumamoto, Kumamoto, Japan · Recruiting

  • Ina Central Hospital

    Ina-shi, Nagano, Japan · Recruiting

  • JISENKAI Healthcare Incorporated Foundation, Aizawa Hospital

    Matsumoto, Nagano, Japan · Recruiting

  • Arakawa Family Clinic

    Nagano, Nagano, Japan · Recruiting

  • Asama General Hospital

    Saku, Nagano, Japan · Recruiting

  • Nara Prefecture General Medical Center

    Nara, Nara, Japan · Recruiting

  • Aizenbashi Hospital

    Osaka, Osaka, Japan · Recruiting

  • Aiwa Hospital

    Kawagoe-shi, Saitama, Japan · Recruiting

  • Hara Children's Clinic

    Tokorozawa, Saitama, Japan · Recruiting

  • Yaizu City Hospital

    Yaizu, Shizuoka, Japan · Recruiting

  • Medical Corporation Asbo Tokyo Asbo Clinic

    Chuo-ku, Tokyo, Japan · Recruiting

  • Aquakids Clinic

    Edogawa-Ku, Tokyo, Japan · Recruiting

  • Okawa Children & Family Clinic

    Ōta-ku, Tokyo, Japan · Recruiting

  • Karugamo Clinic

    Setagaya-Ku, Tokyo, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.